Syal G, Melmed GY, Almario CV, Spiegel BMR, et al. Azathioprine Withdrawal Is Cost-Effective in Patients with Crohn's Disease in Remission on Infliximab and Azathioprine. Dig Dis Sci 2022 Dec 13. doi: 10.1007/s10620-022-07789.
PMID: 36512266